Lead Plaintiff Deadline Nears in Securities Case Targeting Inspire Medical’s Inspire V Launch

Law firms are urging eligible shareholders to seek leadership in the Minnesota federal case by January 5 following allegations that Inspire misrepresented its new device rollout.

Overview

Multiple investor-rights firms, including Rosen, The Schall Law Firm, DJS Law Group, The Gross Law Firm, and Glancy Prongay & Murray, issued fresh reminders and solicitations to investors.
The putative class covers purchases of Inspire Medical Systems stock from August 6, 2024 through August 4, 2025, with a January 5, 2026 deadline to move for lead-plaintiff status.
Complaints allege Inspire overstated market demand for the Inspire V sleep-apnea device and claimed launch readiness that did not exist.
Filings cite operational gaps at launch, including incomplete training and onboarding, missing basic IT and customer-approval processes, insurer claims software not updated, and lack of Medicare reimbursement readiness.
The lawsuit asserts violations of Sections 10(b) and 20(a) and SEC Rule 10b-5, no class has been certified, and investors are not represented unless they retain counsel.